Hera BioLabs

Lexington,  KY 
United States
  • Booth: 1103

Improved models & screening services through gene editing

Hera is a CRO focused on utilizing gene editing to develop more predictive and high throughput in vitro and in vivo models, requiring less reliance on traditional animal models. Hera is working to develop better in vitro models of neurotoxicity, hepatotoxicity and off target hormonal effects with high throughput reporter cell lines.  On the in vivo side, Hera is developing humanized liver and immune system rat models for hepatotoxicity, cancer xenograft, DDI, and immunogenicity testing.   

 Press Releases

Send Email

Type your information and click "Send Email" to send an email to this exhibitor. To return to the previous screen without saving, click "Reset".